Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
27/02/2025 | 00h45 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:SNSE | Sensei Biotherapeutics Inc |
27/02/2025 | 00h44 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:SNSE | Sensei Biotherapeutics Inc |
15/02/2025 | 00h06 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:SNSE | Sensei Biotherapeutics Inc |
15/02/2025 | 00h04 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:SNSE | Sensei Biotherapeutics Inc |
15/02/2025 | 00h03 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:SNSE | Sensei Biotherapeutics Inc |
07/01/2025 | 23h18 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:SNSE | Sensei Biotherapeutics Inc |
23/12/2024 | 22h15 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:SNSE | Sensei Biotherapeutics Inc |
23/12/2024 | 22h15 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:SNSE | Sensei Biotherapeutics Inc |
23/12/2024 | 22h15 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:SNSE | Sensei Biotherapeutics Inc |
23/12/2024 | 22h15 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:SNSE | Sensei Biotherapeutics Inc |
14/11/2024 | 14h03 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:SNSE | Sensei Biotherapeutics Inc |
14/11/2024 | 13h35 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:SNSE | Sensei Biotherapeutics Inc |
30/10/2024 | 21h30 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:SNSE | Sensei Biotherapeutics Inc |
26/09/2024 | 22h36 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | NASDAQ:SNSE | Sensei Biotherapeutics Inc |
20/09/2024 | 22h31 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:SNSE | Sensei Biotherapeutics Inc |
06/08/2024 | 22h30 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:SNSE | Sensei Biotherapeutics Inc |
06/08/2024 | 13h36 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:SNSE | Sensei Biotherapeutics Inc |
12/07/2024 | 22h31 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:SNSE | Sensei Biotherapeutics Inc |
13/06/2024 | 23h10 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:SNSE | Sensei Biotherapeutics Inc |
13/06/2024 | 23h08 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:SNSE | Sensei Biotherapeutics Inc |
13/06/2024 | 23h07 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:SNSE | Sensei Biotherapeutics Inc |
13/06/2024 | 23h06 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:SNSE | Sensei Biotherapeutics Inc |
13/06/2024 | 23h01 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:SNSE | Sensei Biotherapeutics Inc |
13/06/2024 | 22h45 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:SNSE | Sensei Biotherapeutics Inc |
03/06/2024 | 13h31 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:SNSE | Sensei Biotherapeutics Inc |
23/05/2024 | 23h10 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:SNSE | Sensei Biotherapeutics Inc |
09/05/2024 | 22h31 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:SNSE | Sensei Biotherapeutics Inc |
09/05/2024 | 13h37 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:SNSE | Sensei Biotherapeutics Inc |
05/03/2024 | 22h44 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:SNSE | Sensei Biotherapeutics Inc |
28/02/2024 | 13h31 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:SNSE | Sensei Biotherapeutics Inc |